Search Results - "Dragojevic, Sonja"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Circumventing Doxorubicin Resistance Using Elastin-like Polypeptide Biopolymer-Mediated Drug Delivery by Dragojevic, Sonja, Turner, Lindsay, Raucher, Drazen

    “…Although doxorubicin (dox), an anthracycline antibiotic, is widely used and effective in treating cancer, its treatment efficiency is limited by low blood…”
    Get full text
    Journal Article
  2. 2

    Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy by Dragojevic, Sonja, Ryu, Jung Su, Raucher, Drazen

    Published in Molecules (Basel, Switzerland) (04-12-2015)
    “…The majority of anticancer drugs have poor aqueous solubility, produce adverse effects in healthy tissue, and thus impose major limitations on both clinical…”
    Get full text
    Journal Article
  3. 3

    Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives by Raucher, Drazen, Dragojevic, Sonja, Ryu, Jungsu

    Published in Frontiers in oncology (17-12-2018)
    “…Glioblastoma, the most common, aggressive brain tumor, ranks among the least curable cancers-owing to its strong tendency for intracranial dissemination, high…”
    Get full text
    Journal Article
  4. 4

    Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma by Dragojevic, Sonja, Mackey, Rebecca, Raucher, Drazen

    Published in Molecules (Basel, Switzerland) (06-09-2019)
    “…To increase treatment efficiency for glioblastoma, we have developed a system to selectively deliver chemotherapeutic doxorubicin (Dox) to Glioblastoma (GBM)…”
    Get full text
    Journal Article
  5. 5

    Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity by Dragojevic, Sonja, Ryu, Jung Su, Hall, Michael E, Raucher, Drazen

    Published in Molecules (Basel, Switzerland) (24-05-2022)
    “…The anticancer agent doxorubicin(dox) has been widely used in the treatment of a variety of hematological malignancies and solid tumors. Despite doxorubicin's…”
    Get full text
    Journal Article
  6. 6

    Elastin-like Polypeptide Hydrogels for Tunable, Sustained Local Chemotherapy in Malignant Glioma by Dragojevic, Sonja, Turner, Lindsay, Pal, Pallabi, Janorkar, Amol V, Raucher, Drazen

    Published in Pharmaceutics (28-09-2022)
    “…Glioblastoma (GBM) is a primary brain tumor that carries a dismal prognosis, which is primarily attributed to tumor recurrence after surgery and resistance to…”
    Get full text
    Journal Article
  7. 7

    Thermally Targeted p50 Peptide Inhibits Proliferation and Induces Apoptosis of Breast Cancer Cell Lines by Thomas, Emily, Dragojevic, Sonja, Price, Amira, Raucher, Drazen

    Published in Macromolecular bioscience (01-10-2020)
    “…The application of rationally designed therapeutic peptides (TP) may improve outcomes in cancer treatment. These peptides hold the potential to directly target…”
    Get full text
    Journal Article
  8. 8

    Abstract 3708: Targeted delivery of doxorubicin to glioblastomas by thermally sensitive polypeptides by Dragojevic, Sonja, Mackey, Rebecca B., Kratz, Felix, Raucher, Drazen

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Abstract Glioblastoma (GBM) ranks among the most common, aggressive, and least curable cancers due to a strong tendency for intracranial dissemination, high…”
    Get full text
    Journal Article
  9. 9

    Central Nervous System Delivery of the Catalytic Subunit of DNA-Dependent Protein Kinase Inhibitor Peposertib as Radiosensitizer for Brain Metastases by Talele, Surabhi, Zhang, Wenjuan, Oh, Ju-Hee, Burgenske, Danielle M, Mladek, Ann C, Dragojevic, Sonja, Sarkaria, Jann N, Elmquist, William F

    “…Cytotoxic effects of chemotherapy and radiation therapy (RT) used for the treatment of brain metastases results from DNA damage within cancer cells. Cells rely…”
    Get full text
    Journal Article
  10. 10

    Abstract 3106: Targeted delivery via Elastin Like Polypeptide: Biodistribution of a doxorubicin derivative in MDA-MB231 human breast cancer xenografts in mice by Dragojevic, Sonja, Ryu, Jung Su, Kratz, Felix, Raucher, Drazen

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Abstract The anticancer agent doxorubicin has been widely used in the treatment of a variety of hematological malignancies and solid tumors. Despite…”
    Get full text
    Journal Article
  11. 11

    Abstract 2168: Optimizing doxorubicin derivatives delivery using temperature sensitive biopolymers in multidrug resistant breast cancer cells by Dragojevic, Sonja, Ryu, Jung Su, Kratz, Felix, Raucher, Drazen

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract The anticancer agent doxorubicin is an anthracycline compound that shows high potency in treating cancer, and it is one of the most widely used…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Elastin-like Polypeptide for Targeted Delivery of Doxorubicin in the Treatment of Brain and Breast Cancers by Dragojevic, Sonja

    Published 01-01-2019
    “…Cancer represents a diverse group of diseases that can affect almost all organs and body systems. The traditional treatment for cancer is based on a multimodal…”
    Get full text
    Dissertation
  14. 14
  15. 15
  16. 16
  17. 17